-
2022-501417-31-00
5
High-risk Resected Melanoma
-
2023-504989-37-00
5
Metastatic Squamous Non-small Cell Lung Cancer
-
2024-515147-32-02
4
Cocaine addiction
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2025-520538-49-00
1
Moderate-Severe Hypoxic-Ischaemic Encephalopathy (HIE)
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-522748-42-00
5
Ovarian cancer
-
2025-523544-12-00
5
Myelodysplastic neoplasms/syndromes (MDS)
-
2025-523576-23-00
5
Unresectable Stage III non-small cell lung cancer without progression
-
2024-518858-17-00
4
2026-05-22
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
-
2025-522255-25-00
5
2026-05-18
Fallopian Tube Neoplasms
-
2023-508047-40-00
5
2026-04-30
Ovarian cancer
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2024-519901-36-00
5
2025-12-17
Patients with resected stage II-IIIA non-small cell lung cancer (NSCLC
-
2024-518007-22-00
5
2025-12-05
Prevention of monkeypox (mpox) infection
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2024-517500-11-00
7
2025-07-15
Colorectal Cancer
-
2024-518973-32-00
5
2025-07-03
Chronic Graft-Versus-Host Disease
-
2023-508015-23-00
5
2025-04-11
Ovarian cancer recurrent
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2024-515451-38-00
5
2025-02-27
Primary Immune thrombocytopenia (ITP)